Press Release: FDA approves Lymphoseek to help determine the extent of head and neck cancer in the body

The U.S. Food and Drug Administration today approved a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent used to help doctors determine the extent a type of cancer called squamous cell carcinoma has spread in the body's head and neck region.

Food & Drug Administration (FDA), Navidea

News Well, Press Release, Regulatory/Clearance, Food & Drug Administration (FDA), Imaging, Oncology, Pre-Market Approval (PMA)

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1xVIGNC